Xu Liu
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 06, 2025
Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia.
Journal: Frontiers in immunology
Published: February 27, 2023
Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study.
Journal: Experimental hematology & oncology
Published: November 14, 2022
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.
Journal: Frontiers in pediatrics
Published: November 10, 2022
Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis.
Journal: European journal of haematology
Published: September 25, 2022
Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study.
Journal: Therapeutic advances in hematology
Published: July 05, 2022
First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
Journal: Annals of hematology
Published: December 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026